Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Paracelsian improves HIV-1 system model

Aug. 30, 1996

Toyama reveals anti-HIV quinolones

Aug. 30, 1996

Protease inhibitors from Sankyo

Aug. 23, 1996

Biaxin shown to prolong longetivity in AIDS patients

Aug. 23, 1996

Zerit launched in U.K.

Aug. 23, 1996

Zithromax demonstrates prophylactic effect against MAC in AIDS patients

Aug. 23, 1996

Epivir approved for European market

Aug. 23, 1996

Norvir approved by Canadian authorities

Aug. 23, 1996

Dainabot seeks Japanese approval of Norvir

Aug. 23, 1996

Roxane Laboratories has begun U.S. nevirapine distribution

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...